Literature DB >> 32016051

Are we approaching a new era in the treatment of anemia of chronic kidney disease patients?

Francesco Locatelli1, Lucia Del Vecchio1.   

Abstract

Entities:  

Year:  2019        PMID： 32016051      PMCID： PMC6976450          DOI： 10.21037/atm.2019.09.119

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

1.  Clinical experience with darbepoetin-alfa (Aranesp).

Authors:  Francesco Locatelli; Lucia Del Vecchio; Paolo Marai
Journal:  Contrib Nephrol       Date:  2002       Impact factor: 1.580

2.  Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.

Authors:  Francesco Locatelli; Thierry Hannedouche; Steven Fishbane; Zoe Morgan; Delphine Oguey; William B White
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-16       Impact factor: 8.237

3.  Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine.

Authors:  Alexander M Walker; Gary Schneider; Jason Yeaw; Beth Nordstrom; Sean Robbins; Daniel Pettitt
Journal:  J Am Soc Nephrol       Date:  2006-07-12       Impact factor: 10.121

Review 4.  Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.

Authors:  Valeria M Saglimbene; Suetonia C Palmer; Marinella Ruospo; Patrizia Natale; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-08-07

5.  Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies.

Authors:  Kearkiat Praditpornsilpa; Khajohn Tiranathanagul; Pawinee Kupatawintu; Saengsuree Jootar; Tanin Intragumtornchai; Kriang Tungsanga; Tanyarat Teerapornlertratt; Dusit Lumlertkul; Natavudh Townamchai; Paweena Susantitaphong; Pisut Katavetin; Talerngsak Kanjanabuch; Yingyos Avihingsanon; Somchai Eiam-Ong
Journal:  Kidney Int       Date:  2011-03-23       Impact factor: 10.612

6.  Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: one dialysis center experience.

Authors:  Wenxin Zhang; Zhifeng Gong; Xiaomei Peng; Sheng Tang; Ming Bi; Wentan Huang
Journal:  Int Urol Nephrol       Date:  2009-07-14       Impact factor: 2.370

7.  Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.

Authors:  Francesco Locatelli; Peter Bárány; Adrian Covic; Angel De Francisco; Lucia Del Vecchio; David Goldsmith; Walter Hörl; Gerard London; Raymond Vanholder; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2013-04-12       Impact factor: 5.992

8.  Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Authors:  Nan Chen; Chuanming Hao; Bi-Cheng Liu; Hongli Lin; Caili Wang; Changying Xing; Xinling Liang; Gengru Jiang; Zhengrong Liu; Xuemei Li; Li Zuo; Laimin Luo; Jianqin Wang; Ming-Hui Zhao; Zhihong Liu; Guang-Yan Cai; Li Hao; Robert Leong; Chunrong Wang; Cameron Liu; Thomas Neff; Lynda Szczech; Kin-Hung P Yu
Journal:  N Engl J Med       Date:  2019-07-24       Impact factor: 91.245

9.  Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Authors:  Nan Chen; Chuanming Hao; Xiaomei Peng; Hongli Lin; Aiping Yin; Li Hao; Ye Tao; Xinling Liang; Zhengrong Liu; Changying Xing; Jianghua Chen; Laimin Luo; Li Zuo; Yunhua Liao; Bi-Cheng Liu; Robert Leong; Chunrong Wang; Cameron Liu; Thomas Neff; Lynda Szczech; Kin-Hung P Yu
Journal:  N Engl J Med       Date:  2019-07-24       Impact factor: 91.245

Review 10.  HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism.

Authors:  Volker H Haase
Journal:  Hemodial Int       Date:  2017-06       Impact factor: 1.812
View more
  1 in total

1.  STAT1-p53-p21axis-dependent stress-induced progression of chronic nephrosis in adriamycin-induced mouse model.

Authors:  Hua Wei; Jiali Wang; Zhaozhi Liang
Journal:  Ann Transl Med       Date:  2020-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.